Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary Surgery-Reference-Cited by-同舟云学术

Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary Surgery

Published:2019-07-01 Issue:7 Volume:5 Page:961
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kennedy Erin D.¹²³,Simunovic Marko⁴,Jhaveri Kartik⁵⁶,Kirsch Richard⁷,Brierley Jim⁸⁹,Drolet Sébastien¹⁰,Brown Carl¹¹,Vos Patrick M.¹²,Xiong Wei¹³,MacLean Tony¹⁴,Kanthan Selliah¹⁵,Stotland Peter¹⁶,Raphael Simon¹⁷,Chow Gil¹⁸,O’Brien Catherine A.¹⁹,Cho Charles²⁰,Streutker Cathy²¹,Wong Raimond²²,Schmocker Selina¹,Liberman Sender²³,Reinhold Caroline²⁴,Kopek Neil²⁵,Marcus Victoria²⁶,Bouchard Alexandre²⁷,Lavoie Caroline²⁸,Morin Stanislas²⁹,Périgny Martine³⁰,Wright Ann¹⁰,Neumann Katerina³¹,Clarke Sharon³²,Patil Nikhilesh G.³³,Arnason Thomas³⁴,Williams Lara³⁵,McLeod Robin²³,Brown Gina³⁶,Mathieson Alex³⁷,Pooni Amandeep¹,Baxter Nancy N.²³³⁸³⁹

Affiliation:

1. Division of General Surgery, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada

2. Department of Surgery, University of Toronto, Toronto, Ontario, Canada

3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

4. Department of Surgery, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada

5. Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital, Toronto, Ontario, Canada

6. Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada

7. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

8. Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

9. Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada

10. Department of Surgery, Centre Hospitalier Universitaire (CHU) de Quebec, Laval University, Quebec City, Quebec, Canada

11. Department of Surgery, St Paul’s Hospital, Providence Health Care, Vancouver, British Columbia, Canada

12. Department of Radiology, St Paul’s Hospital, Providence Health Care, Vancouver, British Columbia, Canada

13. Department of Pathology & Laboratory Medicine, St Paul’s Hospital, Vancouver, British Columbia, Canada

14. Department of Surgery, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada

15. Department of Surgery, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

16. Department of Surgery, North York General Hospital, Toronto, Ontario, Canada

17. Department of Pathology and Laboratory Medicine, North York General Hospital, Toronto, Ontario, Canada

18. Department of Medical Imaging, North York General Hospital, Toronto, Ontario, Canada

19. Department of Surgery, University Health Network, Toronto, Ontario, Canada

20. Department of Radiation Oncology, Southlake Regional Health Centre, Newmarket, Ontario, Canada

21. Department of Pathology and Laboratory Medicine, St Michael’s Hospital, Toronto, Ontario, Canada

22. Department of Radiation Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ontario, Canada

23. Department of Surgery, McGill University Health Centre (MUHC)–Montreal General Hospital, Montreal, Quebec, Canada

24. Department of Diagnostic Radiology, MUHC–Montreal General Hospital, Montreal, Quebec, Canada

25. Department of Radiation Oncology, MUHC–Montreal General Hospital, Montreal, Quebec, Canada

26. Department of Pathology and Laboratory Medicine, MUHC–Montreal General Hospital, Montreal, Quebec, Canada

27. Department of Surgery, CHU de Quebec, Laval University, Quebec City, Quebec, Canada

28. Department of Radiation Oncology, CHU de Quebec, Laval University, Quebec City, Quebec, Canada

29. Department of Medical Imaging, CHU de Quebec, Laval University, Quebec City, Quebec, Canada

30. Department of Pathology and Laboratory Medicine, CHU de Quebec, Laval University, Quebec City, Quebec, Canada

31. Department of Surgery, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

32. Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

33. Department of Radiation Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

34. Department of Pathology & Laboratory Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

35. Department of Surgery, The Ottawa Hospital, Ottawa, Ontario, Canada

36. Department of Radiology, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, Surrey, England, United Kingdom

37. Department of Surgery, Eastern Health Authority, Memorial University, St John’s, Newfoundland, Canada

38. Division of General Surgery, Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, Ontario, Canada

39. Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/7/961/17712441/jamaoncology_kennedy_2019_oi_190010.pdf

Reference29 articles.

1. Practice parameters for the management of rectal cancer (revised).;Tjandra;Dis Colon Rectum,2005

2. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.;Wong;Clin Oncol (R Coll Radiol),2010

3. Preoperative versus postoperative chemoradiotherapy for rectal cancer.;Sauer;N Engl J Med,2004

4. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.;Kapiteijn;N Engl J Med,2001

5. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.;Sebag-Montefiore;Lancet,2009

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current multidisciplinary management of rectal cancer;Annals of Gastroenterological Surgery;2024-01-27

2. MRI‐defined T3, clear mesorectal fascia mid–low rectal cancer: is neoadjuvant treatment necessary?;Journal of Gastroenterology and Hepatology;2024-01-15

3. Rectal Cancer Update: Which Treatment Effects Are the Least “Brutal”?;International Journal of Radiation Oncology*Biology*Physics;2024-01

4. T3 N1 M0 rectal cancer: optimal initial management is upfront surgery;British Journal of Surgery;2023-11-23

5. Clinical efficacy of Neoadjuvant Chemotherapy combined with Laparoscopic Surgery in patients with Middle and Low Rectal Cancer and its Effect on serum VEGF Levels and quality of life;Pakistan Journal of Medical Sciences;2023-09-09